KiOmed Pharma SA

KiOmed Pharma SA

KiOmed Pharma SA

Overview
Date Founded

2012

Headquarters

Rue Haute Claire 4,Herstal, Walloon Region 4041

Type of Company

Private

Industries

Pharmaceuticals
Holding Companies

Company Description

KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium.

Executives & Employees

Founder

Chief Executive Officer & Managing Director

Chief Operating Officer

Value Stream Director

Subscribe now to see full list of current and former executives
Board of Directors

Founder at KiOmed Pharma SA

Founder at KiOmed Pharma SA

Chief Executive Officer & General Manager at PhysIOL SA

Chief Executive Officer & Managing Director at KiOmed Pharma SA

Subscribe now to see full list of current and former board members
Paths to KiOmed Pharma SA
Potential Connections via
Relationship Science
You
KiOmed Pharma SA
Investors
Details Hidden

Meusinvest is a regional private equity firm focused exclusively on the Liège region and its economic development. The firm invests growth capital in small- to medium-sized companies. They acquire minority interests and aim to pave the way for additional co-investment by banks and private investors. They invest primarily in the form of direct equity, which may be complemented with loans, leasings and bonds, convertible or not. Meusinvest seeks board representation and aims to coach their investee companies in terms of strategy, organization, business management and communication. They leverage an extensive network of partners, both public and private. They favor certain sectors and promote synergies between their portfolio companies.Meusinvest is a long-term investor. The firm stays invested in their portfolio companies for an undetermined period and exits through repurchase by the entrepreneur, at predetermined conditions. Their portfolio consists of a large number of participations in a wide variety of companies in the Liège area.

Details Hidden

KitoZyme SA manufactures biopolymers and provides medical device products. It develops and produces chitosan (and derivatives), chitin-glucan and beta-glucan, exclusively extracted from renewable, non-GMO vegetable sources. The firm specializes in weight management, digestive health and cardiovascular health products. The company was founded in December 2000 and is headquartered in Herstal, Belgium.

Details Hidden

SRIW is an active, long-term manager which invests in companies across a variety of sectors, including environmental activities and technologies, telecommunications, new technologies and medium-priced accommodation, which are capable of promoting the economic development of the Walloon Region. In addition, the SRIW Group contributes to the financing of specific activities including the social economy, aeronautics and space and agricultural products.The firm generally invests at least EUR 620,000, aiming to partner with investee businesses whose administrative and financial organization is sufficiently stable, or soon will be. SRIW takes minority positions in their investee companies, leaving management up to the industrial operator. They typically appoint one or more representatives on the investee company board of directors.

Subscribe now to see full details